Inpatient Drug Discounts For 340B Providers Resurface In Jobs Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
Dropped from health reform, a proposal to extend 340B discounts to inpatient drugs is included in "The American Jobs and Closing Tax Loopholes Act," sponsored by Senate and House committee chairmen.
You may also be interested in...
Technical Fix For Medicaid AMP Definition Would Cost Pharma Firms $2.1 Bil. Over 10 Years, CBO Says
The Senate is considering a provision to fix health care reform law language on calculating average manufacturer prices for Medicaid rebates.
Technical Fix For Medicaid AMP Definition Would Cost Pharma Firms $2.1 Bil. Over 10 Years, CBO Says
The Senate is considering a provision to fix health care reform law language on calculating average manufacturer prices for Medicaid rebates.
340B Drug Allocation Provision In Tax Bill Needs Clarification, Attorney Says
A provision in a tax bill passed by the House May 28 would require manufacturers facing a shortage of an inpatient drug used by 340B program hospitals to submit a drug allocation plan to HHS for approval